BigHat Biosciences Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
85
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$75M
- Investors
-
33
BigHat Biosciences General Information
Description
Developer of antibody discovery and engineering technology designed to accelerate therapeutic development. The company's platform combines artificial intelligence with automated laboratory experimentation to design, synthesize, and evaluate antibodies, enabling biopharmaceutical companies to identify and optimize antibody candidates for therapeutic applications.
Contact Information
Website
www.bighatbio.comCorporate Office
- 1900 Alameda de las Pulgas
- Suite 400
- San Mateo, CA 94403
- United States
Corporate Office
- 1900 Alameda de las Pulgas
- Suite 400
- San Mateo, CA 94403
- United States
BigHat Biosciences Timeline
BigHat Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series C) | 24-Sep-2026 | $75M | Completed | Clinical Trials - Phase 1 | ||
| 8. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 7. Later Stage VC (Series B) | 17-Apr-2025 | Completed | Pre-Clinical Trials | |||
| 6. Early Stage VC (Series B) | 30-Jun-2022 | Completed | Pre-Clinical Trials | |||
| 5. Early Stage VC (Series A) | 10-Feb-2021 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 31-Dec-2020 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 15-Sep-2020 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Sep-2020 | $100K | $5.3M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 22-Oct-2019 | $5.3M | $5.3M | Completed | Startup |
BigHat Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 5,073,699 | $0.000100 | 8% | $3.74 | $3.74 | 1x | $3.74 | 11.04% |
| Seed | 2,599,652 | $0.000100 | 8% | $2.04 | $2.04 | 1x | $2.04 | 5.66% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
BigHat Biosciences Comparisons
Industry
Financing
Details
BigHat Biosciences Competitors (35)
One of BigHat Biosciences’s 35 competitors is InterAx, a Venture Capital-Backed company based in Schlieren, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| InterAx | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Nabla Bio | Venture Capital-Backed | Cambridge, MA | ||||
| Generate Biomedicines | Formerly VC-backed | Somerville, MA | ||||
| ProteinQure | Venture Capital-Backed | Toronto, Canada | ||||
| Manifold Bio | Venture Capital-Backed | Boston, MA |
BigHat Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BigHat Biosciences Patents
BigHat Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026222338-A1 | Anti-ceacam6 t-cell engager bispecific antibodies and uses thereof | Pending | 17-Apr-2025 | ||
| WO-2026035986-A1 | Humanized anti-cdh17 antibodies and use of the same | Pending | 07-Aug-2024 | ||
| EP-4747286-A1 | P- and e-selectin-binding compositions and methods of use thereof | Pending | 21-Jul-2023 | ||
| WO-2025024323-A1 | P- and e-selectin-binding compositions and methods of use thereof | Inactive | 21-Jul-2023 | ||
| EP-4658676-A2 | Anti-cdh17 antibodies and use of the same | Pending | 31-Jan-2023 | C07K16/28 |
BigHat Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BigHat Biosciences Investors (33)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| DFJ Growth | Venture Capital | Minority | ||
| LG Technology Ventures | Corporate Venture Capital | Minority | ||
| Premji Invest (US) | Growth/Expansion | Minority | ||
| Sigmas Group | Asset Manager | Minority |
BigHat Biosciences Acquisitions (1)
BigHat Biosciences’s most recent deal was a Merger/Acquisition with Frugi Biotechnology. The deal was made on 28-Mar-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Frugi Biotechnology | 28-Mar-2022 | Merger/Acquisition | Discovery Tools (Healthcare) |
BigHat Biosciences FAQs
-
When was BigHat Biosciences founded?
BigHat Biosciences was founded in 2019.
-
Where is BigHat Biosciences headquartered?
BigHat Biosciences is headquartered in San Mateo, CA.
-
What is the size of BigHat Biosciences?
BigHat Biosciences has 85 total employees.
-
What industry is BigHat Biosciences in?
BigHat Biosciences’s primary industry is Drug Discovery.
-
Is BigHat Biosciences a private or public company?
BigHat Biosciences is a Private company.
-
What is the current valuation of BigHat Biosciences?
The current valuation of BigHat Biosciences is .
-
What is BigHat Biosciences’s current revenue?
The current revenue for BigHat Biosciences is .
-
How much funding has BigHat Biosciences raised over time?
BigHat Biosciences has raised $223M.
-
Who are BigHat Biosciences’s investors?
Alexandria Venture Investments, DFJ Growth, LG Technology Ventures, Premji Invest (US), and Sigmas Group are 5 of 33 investors who have invested in BigHat Biosciences.
-
Who are BigHat Biosciences’s competitors?
InterAx, Nabla Bio, Generate Biomedicines, ProteinQure, and Manifold Bio are some of the 35 competitors of BigHat Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
